{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T09:36:48Z","timestamp":1792143408444,"version":"4.4.0"},"reference-count":88,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["M\u00e9decine et Maladies Infectieuses"],"published-print":{"date-parts":[[2018,8]]},"DOI":"10.1016\/j.medmal.2018.03.005","type":"journal-article","created":{"date-parts":[[2018,5,16]],"date-time":"2018-05-16T19:34:34Z","timestamp":1526499274000},"page":"327-358","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":183,"title":["Practice guidelines for the management of adult community-acquired urinary tract infections"],"prefix":"10.1016","volume":"48","author":[{"given":"F.","family":"Caron","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Galperine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Flateau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Azria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Bonacorsi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Bruy\u00e8re","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Cariou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Clouqueur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Cohen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Doco-Lecompte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Elefant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Faure","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Gauzit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Gavazzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Lemaitre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Raymond","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Senneville","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Sotto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Subtil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Trivalle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Merens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Etienne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.medmal.2018.03.005_bib0005","series-title":"Elaboration de recommandations de bonne pratique","author":"Haute Autorit\u00e9 de Sant\u00e9","year":"2010"},{"key":"10.1016\/j.medmal.2018.03.005_bib0010","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1086\/427507","article-title":"Infectious Diseases Society of America guidelines for the diagnosis and treatment of asymptomatic bacteriuria in adults","volume":"40","author":"Nicolle","year":"2005","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.medmal.2018.03.005_bib0015","doi-asserted-by":"crossref","first-page":"M146","DOI":"10.1093\/gerona\/56.3.M146","article-title":"Frailty in older adults: evidence for a phenotype","volume":"56","author":"Fried","year":"2001","journal-title":"J Gerontol a Biol Sci Med Sci"},{"key":"10.1016\/j.medmal.2018.03.005_bib0020","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1001\/jama.2016.0287","article-title":"The third international consensus definitions for sepsis and septic shock (Sepsis-3)","volume":"315","author":"Singer","year":"2016","journal-title":"Jama"},{"key":"10.1016\/j.medmal.2018.03.005_bib0025","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1111\/acem.12171","article-title":"History and physical examination plus laboratory testing for the diagnosis of adult female urinary tract infection","volume":"20","author":"Meister","year":"2013","journal-title":"Acad Emerg Med"},{"key":"10.1016\/j.medmal.2018.03.005_bib0030","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1086\/521254","article-title":"Evaluation of the nitrite and leukocyte esterase activity tests for the diagnosis of acute symptomatic urinary tract infection in men","volume":"45","author":"Koeijers","year":"2007","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.medmal.2018.03.005_bib0035","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1086\/528873","article-title":"Performance of the urine leukocyte esterase and nitrite dipstick test for the diagnosis of acute prostatitis","volume":"46","author":"Etienne","year":"2008","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.medmal.2018.03.005_bib0040","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1046\/j.1198-743x.2001.00237.x","article-title":"European guidelines for urinalysis: a collaborative document produced by European clinical microbiologists and clinical chemists under ECLM in collaboration with ESCMID","volume":"7","author":"Aspevall","year":"2001","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.medmal.2018.03.005_bib0045","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1056\/NEJMoa1302186","article-title":"Voided midstream urine culture and acute cystitis in premenopausal women","volume":"369","author":"Hooton","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.medmal.2018.03.005_bib0050","unstructured":"Onerba (Observatoire National de l\u2019\u00e9pid\u00e9miologie de la R\u00e9sistance Bact\u00e9rienne aux Antibiotiques)\u00a0: rapport d\u201dactivit\u00e9 2015\u20132016. n.d. http:\/\/www.onerba.org\/spip.php?article137 (published online, Nov 2016)."},{"key":"10.1016\/j.medmal.2018.03.005_bib0055","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.jinf.2008.12.009","article-title":"Antibiotics versus placebo in the treatment of women with uncomplicated cystitis: A meta-analysis of randomized controlled trials","volume":"58","author":"Falagas","year":"2009","journal-title":"J Infect"},{"key":"10.1016\/j.medmal.2018.03.005_bib0060","first-page":"729","article-title":"Randomised controlled trial of nitrofurantoin versus placebo in the treatment of uncomplicated urinary tract infection in adult women","volume":"52","author":"Christiaens","year":"2002","journal-title":"Br J Gen Pract"},{"key":"10.1016\/j.medmal.2018.03.005_bib0065","unstructured":"EUCAST ECOAST. Clinical breakpoints n. d. http:\/\/www.eucast.org\/clinical_breakpoints\/ (published online, March the 3rd, 2017)."},{"key":"10.1016\/j.medmal.2018.03.005_bib0070","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.medmal.2011.07.005","article-title":"French results of the ARESC study: clinical aspects and epidemiology of antimicrobial resistance in female patients with cystitis. Implications for empiric therapy","volume":"42","author":"Neuzillet","year":"2012","journal-title":"Med Malad Infect"},{"key":"10.1016\/j.medmal.2018.03.005_bib0075","unstructured":"De Mouy D, Janvier F, M\u00e9rens A, Arzouni JP, Bouilloux JP, Dinnat-Courtiols N, et al. Sensibilit\u00e9 d\u2019Escherichia coli aux quinolones et aux c\u00e9phalosporines de troisi\u00e8me g\u00e9n\u00e9ration dans les infections urinaires communautaires\u00a0: \u00e9tude AFORCOPI-BIO 2011. 32e Reunion Interdisciplinaire De Chimioth\u00e9rapie Anti-Infectieuse, Paris, 2012."},{"key":"10.1016\/j.medmal.2018.03.005_bib0080","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1186\/1471-2334-14-137","article-title":"Antibiotic treatment of acute uncomplicated cystitis based on rapid urine test and local epidemiology: lessons from a primary care series","volume":"14","author":"Etienne","year":"2014","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.medmal.2018.03.005_bib0085","series-title":"Epid\u00e9miologie des py\u00e9lon\u00e9phrites et des prostatites communautaires en France\u00a0: les recommandations pour les traitements probabilistes sont-elles toujours adapt\u00e9es?","author":"Saidani","year":"2013"},{"key":"10.1016\/j.medmal.2018.03.005_bib0090","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.medmal.2014.03.003","article-title":"Antibiotic resistance in adult female patients hospitalized for acute pyelonephritis: Rates and predicting factors","volume":"44","author":"Etienne","year":"2014","journal-title":"Med Malad Infect"},{"issue":"Suppl 5","key":"10.1016\/j.medmal.2018.03.005_bib0095","doi-asserted-by":"crossref","first-page":"227","DOI":"10.2165\/00003495-198500295-00050","article-title":"Influence of temocillin on colonisation resistance and consequences for therapy","volume":"29","author":"De Vries-Hospers","year":"1985","journal-title":"Drugs"},{"key":"10.1016\/j.medmal.2018.03.005_bib0100","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1093\/jac\/dku542","article-title":"Activity of temocillin in a murine model of urinary tract infection due to Escherichia coli producing or not producing the ESBL CTX-M-15","volume":"70","author":"Soubirou","year":"2015","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.medmal.2018.03.005_bib0105","doi-asserted-by":"crossref","first-page":"2628","DOI":"10.1093\/jac\/dkr317","article-title":"Temocillin use in England: clinical and microbiological efficacies in infections caused by extended-spectrum and\/or derepressed AmpC -lactamase-producing Enterobacteriaceae","volume":"66","author":"Balakrishnan","year":"2011","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.medmal.2018.03.005_bib0110","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.medmal.2013.01.006","article-title":"Alternatives to carbapenems in ESBL-producing","volume":"43","author":"Fournier","year":"2013","journal-title":"Med Malad Infect"},{"key":"10.1016\/j.medmal.2018.03.005_bib0115","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.medmal.2013.12.004","article-title":"Frequency and epidemiology of extended-spectrum \u03b2-lactamase-producing Enterobacteriaceae isolates susceptible to third-generation cephalosporins or to aztreonam","volume":"44","author":"Bert","year":"2014","journal-title":"Med Malad Infect"},{"key":"10.1016\/j.medmal.2018.03.005_bib0120","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.ijantimicag.2011.09.013","article-title":"Antimicrobial susceptibility of Escherichia coli from community-acquired urinary tract infections in Europe: the ECO\u00b7SENS study revisited","volume":"39","author":"Kahlmeter","year":"2012","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.medmal.2018.03.005_bib0125","series-title":"Enqu\u00eate TMP-UR, r\u00e9union Inter-disciplinaire de chimioth\u00e9rapie anti-infectieuse","author":"ONERBA (Observatoire national de l\u2019\u00e9pid\u00e9miologie de la r\u00e9sistance bact\u00e9rienne aux antibiotiques)","year":"2016"},{"issue":"4","key":"10.1016\/j.medmal.2018.03.005_bib0130","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.medmal.2016.12.001","article-title":"The comeback of trimethoprim in France","volume":"47","author":"Caron","year":"2017","journal-title":"Med Malad Infect"},{"key":"10.1016\/j.medmal.2018.03.005_bib0135","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1007\/s40121-015-0095-5","article-title":"Antimicrobial resistance of Escherichia coli causing uncomplicated urinary tract infections: a european update for 2014 and comparison with 2000 and 2008","volume":"4","author":"Kahlmeter","year":"2015","journal-title":"Infect Dis Ther"},{"key":"10.1016\/j.medmal.2018.03.005_bib0140","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0924-8579(98)00021-1","article-title":"A comparison between single-dose fosfomycin trometamol (Monuril) and a 5-day course of trimethoprim in the treatment of uncomplicated lower urinary tract infection in women","volume":"10","author":"Minassian","year":"1998","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.medmal.2018.03.005_bib0145","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.1016\/S0149-2918(00)86734-X","article-title":"Comparison of single-dose fosfomycin and a 7-day course of nitrofurantoin in female patients with uncomplicated urinary tract infection","volume":"21","author":"Stein","year":"1999","journal-title":"Clin Ther"},{"key":"10.1016\/j.medmal.2018.03.005_bib0150","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S1473-3099(09)70325-1","article-title":"Fosfomycin for the treatment of multidrug-resistant, including extended-spectrum (-lactamase producing, Enterobacteriaceae infections: a systematic review","volume":"10","author":"Falagas","year":"2010","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.medmal.2018.03.005_bib0155","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1007\/s10156-010-0079-z","article-title":"A randomized comparative study of single-dose fosfomycin and 5-day ciprofloxacin in female patients with uncomplicated lower urinary tract infections","volume":"16","author":"Ceran","year":"2010","journal-title":"J Infect Chemother"},{"key":"10.1016\/j.medmal.2018.03.005_bib0160","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1080\/00365540110080728","article-title":"Three days of pivmecillinam or norfloxacin for treatment of acute uncomplicated urinary infection in women","volume":"34","author":"Nicolle","year":"2002","journal-title":"Scand J Infect Dis"},{"key":"10.1016\/j.medmal.2018.03.005_bib0165","doi-asserted-by":"crossref","DOI":"10.1080\/02813430601183074","article-title":"Clinical and bacteriological outcome of different doses and duration of pivmecillinam compared with placebo therapy of uncomplicated lower urinary tract infection in women: the LUTIW project","author":"Ferry","year":"2007","journal-title":"Scand J Prim Health Care"},{"key":"10.1016\/j.medmal.2018.03.005_bib0170","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1080\/02813430802535312","article-title":"Pivmecillinam versus sulfamethizole for short-term treatment of uncomplicated acute cystitis in general practice: A randomized controlled trial","volume":"27","author":"Bjerrum","year":"2009","journal-title":"Scand J Prim Health Care"},{"issue":"344","key":"10.1016\/j.medmal.2018.03.005_bib0175","first-page":"e1","article-title":"Collateral damage from oral ciprofloxacin versus nitrofurantoin in outpatients with urinary tract infections: a culture-free analysis of gut microbiota","volume":"21","author":"Stewardson","year":"2015","journal-title":"Clin Microbio Infect"},{"key":"10.1016\/j.medmal.2018.03.005_bib0180","series-title":"Restriction d\u2019utilisation de la nitrofuranto\u00efne en raison d\u2019un risque de survenue d\u2019effets ind\u00e9sirablesgraves h\u00e9patiques et pulmonaires","author":"Agence Nationale de S\u00e9curit\u00e9 des M\u00e9dicaments (ANSM)","year":"2012"},{"key":"10.1016\/j.medmal.2018.03.005_bib0185","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1001\/archinte.168.17.1897","article-title":"Community infections caused by extended-spectrum beta-lactamase-producing Escherichia coli","volume":"168","author":"Rodr\u00edguez-Ba\u00f1o","year":"2008","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.medmal.2018.03.005_bib0190","series-title":"Pivm\u00e9cillinam et cystites communautaires \u00e0 E.\u00a0coli: sensibilit\u00e9 in vitro","author":"Bugier","year":"2015"},{"key":"10.1016\/j.medmal.2018.03.005_bib0195","series-title":"Sensibilit\u00e9 de E.\u00a0coli aux antibiotiques dans les infections urinaires communautaires en fonction des tableaux cliniques","author":"Parent-Poyeto","year":"2015"},{"key":"10.1016\/j.medmal.2018.03.005_bib0200","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.ijantimicag.2016.04.014","article-title":"Comparison of fosfomycin to ertapenem for outpatient or step-down therapy of extended-spectrum \u03b2-lactamase urinary tract infections","volume":"48","author":"Veve","year":"2016","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.medmal.2018.03.005_bib0205","first-page":"7","article-title":"Practical management of recurrent urinary tract infections in premenopausal women","volume":"122","author":"Nickel","year":"2005","journal-title":"Rev Urol"},{"key":"10.1016\/j.medmal.2018.03.005_bib0210","doi-asserted-by":"crossref","first-page":"316","DOI":"10.5489\/cuaj.687","article-title":"Guidelines for the diagnosis and management of recurrent urinary tract infection in women","volume":"5","author":"Dason","year":"2011","journal-title":"Can Urol Assoc J"},{"key":"10.1016\/j.medmal.2018.03.005_bib0215","first-page":"207","article-title":"Efficacy and safety of self-start therapy in women with recurrent urinary tract infections","volume":"161","author":"Schaeffer","year":"1999","journal-title":"Juro"},{"key":"10.1016\/j.medmal.2018.03.005_bib0220","doi-asserted-by":"crossref","first-page":"9","DOI":"10.7326\/0003-4819-135-1-200107030-00004","article-title":"Patient-initiated treatment of uncomplicated recurrent urinary tract infections in young women","volume":"135","author":"Gupta","year":"2001","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.medmal.2018.03.005_bib0225","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.idc.2013.10.001","article-title":"Prevention of recurrent urinary tract infections in women: antimicrobial and nonantimicrobial strategies","volume":"28","author":"Geerlings","year":"2014","journal-title":"Infect Dis Clin North Am"},{"key":"10.1016\/j.medmal.2018.03.005_bib0230","first-page":"CD001209","article-title":"Antibiotics for preventing recurrent urinary tract infection in non-pregnant women","author":"Albert","year":"2004","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.medmal.2018.03.005_bib0235","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1093\/jac\/16.1.111","article-title":"A clinical comparison between Macrodantin and trimethoprim for prophylaxis in women with recurrent urinary infections","volume":"16","author":"Brumfitt","year":"1985","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.medmal.2018.03.005_bib0240","first-page":"420","article-title":"Prevention of recurrent lower urinary tract infections by long-term administration of fosfomycin trometamol. Double blind, randomized, parallel group, placebo controlled study","volume":"55","author":"Rudenko","year":"2005","journal-title":"Arzneimittelforschung"},{"key":"10.1016\/j.medmal.2018.03.005_bib0245","first-page":"935","article-title":"Post-intercourse versus daily ciprofloxacin prophylaxis for recurrent urinary tract infections in premenopausal women","volume":"157","author":"Melekos","year":"1997","journal-title":"Juro"},{"key":"10.1016\/j.medmal.2018.03.005_bib0250","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/S0002-9343(88)80023-8","article-title":"Pyelonephritis in adult women: inpatient versus outpatient therapy","volume":"85","author":"Safrin","year":"1988","journal-title":"Am J Med"},{"key":"10.1016\/j.medmal.2018.03.005_bib0255","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.jinf.2010.10.009","article-title":"Impact of discordant empirical therapy on outcome of community-acquired bacteremic acute pyelonephritis","volume":"62","author":"Lee","year":"2011","journal-title":"J Infect"},{"key":"10.1016\/j.medmal.2018.03.005_bib0260","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.jinf.2005.12.005","article-title":"Are blood cultures necessary in the management of women with complicated pyelonephritis?","volume":"53","author":"Chen","year":"2006","journal-title":"J Infect"},{"key":"10.1016\/j.medmal.2018.03.005_bib0265","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1086\/378291","article-title":"Blood cultures for women with uncomplicated acute pyelonephritis: are they necessary?","volume":"37","author":"Velasco","year":"2003","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.medmal.2018.03.005_bib0270","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1086\/657071","article-title":"Predicting the need for radiologic imaging in adults with febrile urinary tract infection","volume":"51","author":"van Nieuwkoop","year":"2010","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.medmal.2018.03.005_bib0275","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1001\/jama.283.12.1583","article-title":"Comparison of ciprofloxacin (7 days) and trimethoprim-sulfamethoxazole (14 days) for acute uncomplicated pyelonephritis pyelonephritis in women: a randomized trial","volume":"283","author":"Talan","year":"2000","journal-title":"JAMA"},{"key":"10.1016\/j.medmal.2018.03.005_bib0280","article-title":"Guidelines on urological infections","author":"Grabe","year":"2015","journal-title":"Euro Assoc Urol"},{"key":"10.1016\/j.medmal.2018.03.005_bib0285","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1128\/AAC.01228-08","article-title":"Prevalence and risk factors for selection of quinolone-resistant Escherichia coli strains in fecal flora of patients receiving quinolone therapy","volume":"53","author":"Yagci","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.medmal.2018.03.005_bib0290","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1093\/jac\/dks406","article-title":"Antibiotics involved in the occurrence of antibiotic-resistant bacteria: a nationwide multilevel study suggests differences within antibiotic classes","volume":"68","author":"Gbaguidi-Haore","year":"2013","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.medmal.2018.03.005_bib0295","first-page":"183","article-title":"Prospective, randomized, controlled study comparing two dosing regimens of gentamicin\/oral ciprofloxacin switch therapy for acute pyelonephritis","volume":"46","author":"Bailey","year":"1996","journal-title":"Clin Nephrol"},{"key":"10.1016\/j.medmal.2018.03.005_bib0300","doi-asserted-by":"crossref","first-page":"e103","DOI":"10.1093\/cid\/ciq257","article-title":"International clinical practice guidelines for the treatment of acute uncomplicated cystitis and pyelonephritis in women: a 2010 update by the Infectious Diseases Society of America and the European Society for Microbiology and Infectious Diseases","volume":"52","author":"Gupta","year":"2011","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.medmal.2018.03.005_bib0305","doi-asserted-by":"crossref","first-page":"e269","DOI":"10.1542\/peds.2011-0814","article-title":"Randomized trial of oral versus sequential IV\/oral antibiotic for acute pyelonephritis in children","volume":"129","author":"Bocquet","year":"2012","journal-title":"Pediatrics"},{"key":"10.1016\/j.medmal.2018.03.005_bib0310","doi-asserted-by":"crossref","first-page":"2637","DOI":"10.1185\/030079907X233340","article-title":"A trial of levofloxacin 750 mg once daily for 5 days versus ciprofloxacin 400 mg and\/or 500 mg twice daily for 10 days in the treatment of acute pyelonephritis","volume":"23","author":"Klausner","year":"2007","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.medmal.2018.03.005_bib0315","series-title":"Is 5 days of oral fluoroquinolone enough for acute uncomplicated pyelonephritis? The DTP randomized trial","first-page":"1","author":"Dinh","year":"2017"},{"key":"10.1016\/j.medmal.2018.03.005_bib0320","first-page":"102","article-title":"Comparison of ciprofloxacin with netilmicin for the treatment of acute pyelonephritis","volume":"105","author":"Bailey","year":"1992","journal-title":"N Z Med J"},{"key":"10.1016\/j.medmal.2018.03.005_bib0325","series-title":"Mise au point sur le bon usage des aminosides administr\u00e9s par voie injectable\u00a0: gentamicine, tobramycine, n\u00e9tilmicine, amikacine","first-page":"1","author":"Agence fran\u00e7aise de s\u00e9curit\u00e9 sanitaire et de produits de sant\u00e9 (AFSSAPS)","year":"2011"},{"key":"10.1016\/j.medmal.2018.03.005_bib0330","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1097\/CCM.0b013e3181eb3ccd","article-title":"Early combination antibiotic therapy yields improved survival compared with monotherapy in septic shock: a propensity-matched analysis","volume":"38","author":"Kumar","year":"2010","journal-title":"Crit Care Med"},{"key":"10.1016\/j.medmal.2018.03.005_bib0335","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01365-09","article-title":"Empiric combination antibiotic therapy is associated with improved outcome in gram-negative sepsis: a retrospective analysis","author":"Micek","year":"2010","journal-title":"Antimicrob Agents"},{"key":"10.1016\/j.medmal.2018.03.005_bib0340","doi-asserted-by":"crossref","first-page":"3590","DOI":"10.1128\/AAC.00115-10","article-title":"Influence of empiric therapy with a beta-lactam alone or combined with an aminoglycoside on prognosis of bacteremia due to gram-negative microorganisms","volume":"54","author":"Martinez","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.medmal.2018.03.005_bib0345","doi-asserted-by":"crossref","first-page":"2793","DOI":"10.1093\/jac\/dks301","article-title":"Carbapenems versus alternative antibiotics for the treatment of bacteraemia due to Enterobacteriaceae producing extended-spectrum -lactamases: a systematic review and meta-analysis","volume":"67","author":"Vardakas","year":"2012","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.medmal.2018.03.005_bib0350","doi-asserted-by":"crossref","first-page":"30014","DOI":"10.2807\/1560-7917.ES.2015.20.36.30014","article-title":"Ongoing increasing temporal and geographical trends of the incidence of extended-spectrum beta-lactamase-producing Enterobacteriaceaeinfections in France, 2009 to 2013","volume":"20","author":"Arnaud","year":"2015","journal-title":"Euro Surveill"},{"key":"10.1016\/j.medmal.2018.03.005_bib0355","doi-asserted-by":"crossref","first-page":"2982","DOI":"10.1093\/jac\/dks300","article-title":"Epidemiology and genetic characteristics of extended-spectrum -lactamase-producing Gram-negative bacteria causing urinary tract infections in long-term care facilities","volume":"67","author":"Tinelli","year":"2012","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.medmal.2018.03.005_bib0360","first-page":"CD000490","article-title":"Antibiotics for asymptomatic bacteriuria in pregnancy","author":"Smaill","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.medmal.2018.03.005_bib0365","unstructured":"Haute Autorit\u00e9 de Sant\u00e9. Suivi et orientation des femmes enceintes en fonction des situations \u00e0 risques identifi\u00e9es n.d. https:\/\/www.has-sante.fr\/portail\/jcms\/c_547976\/fr\/suivi-et-orientation-des-femmes-enceintes-en-fonction-des-situations-a-risque-identifiees (accessed Dec 9, 2017)"},{"key":"10.1016\/j.medmal.2018.03.005_bib0370","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1093\/jac\/13.4.383","article-title":"Pivmecillinam for bacteriuria in pregnancy","volume":"13","author":"Sanderson","year":"1984","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.medmal.2018.03.005_bib0375","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1007\/s10096-009-0805-6","article-title":"Fosfomycin in a single dose versus a 7-day course of amoxicillin-clavulanate for the treatment of asymptomatic bacteriuria during pregnancy","volume":"28","author":"Estebanez","year":"2009","journal-title":"Euro J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.medmal.2018.03.005_bib0380","first-page":"CD000491","article-title":"Duration of treatment for asymptomatic bacteriuria during pregnancy","author":"Widmer","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.medmal.2018.03.005_bib0385","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S0140-6736(84)90242-3","article-title":"Rupture of fetal membranes and premature delivery associated with group B streptococci in urine of pregnant women","volume":"2","author":"M\u00f8ller","year":"1984","journal-title":"Lancet"},{"key":"10.1016\/j.medmal.2018.03.005_bib0390","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/S0140-6736(87)90234-0","article-title":"Antibiotic elimination of group-B streptococci in urine in prevention of preterm labour","volume":"1","author":"Thomsen","year":"1987","journal-title":"Lancet"},{"key":"10.1016\/j.medmal.2018.03.005_bib0395","first-page":"CD002256","article-title":"Treatments for symptomatic urinary tract infections during pregnancy","author":"Vazquez","year":"2011","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.medmal.2018.03.005_bib0400","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0924-8579(03)00235-8","article-title":"Pivmecillinam therapy of choice for lower urinary tract infection","volume":"22","author":"Graninger Austria","year":"2003","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.medmal.2018.03.005_bib0405","first-page":"249","article-title":"A randomized trial of three antibiotic regimens for the treatment of pyelonephritis in pregnancy","volume":"92","author":"Wing","year":"1998","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.medmal.2018.03.005_bib0410","doi-asserted-by":"crossref","first-page":"1935","DOI":"10.1128\/JCM.00425-10","article-title":"Should blood cultures be performed for patients with acute prostatitis?","volume":"48","author":"Etienne","year":"2010","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.medmal.2018.03.005_bib0415","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1016\/j.purol.2013.05.009","article-title":"[PSA interest and prostatitis: literature review]","volume":"23","author":"Bruy\u00e8re","year":"2013","journal-title":"Prog Urol"},{"key":"10.1016\/j.medmal.2018.03.005_bib0420","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1046\/j.1464-410x.1999.00164.x","article-title":"Prostatic involvement in men with febrile urinary tract infection as measured by serum prostate-specific antigen and transrectal ultrasonography","volume":"84","author":"Ulleryd","year":"2001","journal-title":"BJU Int"},{"key":"10.1016\/j.medmal.2018.03.005_bib0425","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1001\/2013.jamainternmed.829","article-title":"Urinary tract infection in male veterans","volume":"173","author":"Drekonja","year":"2013","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.medmal.2018.03.005_bib0430","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1080\/0036554021000026988","article-title":"Ciprofloxacin for 2 or 4 weeks in the treatment of febrile urinary tract infection in men: a randomized trial with a 1 year follow-up","volume":"35","author":"Ulleryd","year":"2003","journal-title":"Scand J Infect Dis"},{"key":"10.1016\/j.medmal.2018.03.005_bib0435","doi-asserted-by":"crossref","first-page":"F123","DOI":"10.1016\/j.fpurol.2009.09.001","article-title":"R\u00e9tention aigu\u00eb d\u2019urine sur prostatite aigu\u00eb: sonde v\u00e9sicale ou cath\u00e9ter sus-pubien?","volume":"19","author":"Bruy\u00e8re","year":"2009","journal-title":"Prog Urol FMC"},{"key":"10.1016\/j.medmal.2018.03.005_bib0440","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1046\/j.1464-410x.2001.02252.x","article-title":"Selective urological evaluation in men with febrile urinary tract infection","volume":"88","author":"Ulleryd","year":"2001","journal-title":"BJU Int"}],"container-title":["M\u00e9decine et Maladies Infectieuses"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0399077X17310363?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0399077X17310363?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T01:16:46Z","timestamp":1759972606000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0399077X17310363"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8]]},"references-count":88,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2018,8]]}},"alternative-id":["S0399077X17310363"],"URL":"https:\/\/doi.org\/10.1016\/j.medmal.2018.03.005","relation":{},"ISSN":["0399-077X"],"issn-type":[{"value":"0399-077X","type":"print"}],"subject":[],"published":{"date-parts":[[2018,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Practice guidelines for the management of adult community-acquired urinary tract infections","name":"articletitle","label":"Article Title"},{"value":"M\u00e9decine et Maladies Infectieuses","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.medmal.2018.03.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}